Considering the ECOG PS and LDH were candidate prognostic factors in several cancer types, we further evaluated the predictive and prognostic abilities of PILE, a candidate prognostic score, among anti-PD-1/L1 inhibitor-treated patients with SCLC. This evidence concerns the gene PDCD1 and small cell lung carcinoma.